Efficacy of therapeutic drug monitoring in prevention of hypoglycemia caused by cibenzoline

European Journal of Clinical Pharmacology

Volumn 57, Issue 10, 2001, Pages 695-700

  Takada, M ^a   Shibakawa, M ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Cibenzoline; Hypoglycemia; Therapeutic drug monitoring

Indexed keywords

CIBENZOLINE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MONITORING; FEMALE; HUMAN; HYPOGLYCEMIA; MALE; PRIORITY JOURNAL; RISK; STATISTICAL ANALYSIS;

ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; CASE-CONTROL STUDIES; DRUG MONITORING; FEMALE; HUMANS; HYPOGLYCEMIA; IMIDAZOLES; MALE; MIDDLE AGED;

EID: 0035664470     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-001-0381-x     Document Type: Article

References (18)

1. Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: A case/non-case study in the French pharmacovigilance system database
2. Drug-induced hypoglycemia. A review of 1418 cases
3. Cibenzoline and hypoglycaemia
4. Hypoglycaemia induced by cibenzoline
5. The relationship between risk of hypoglycemia and use of cibenzoline and disopyramide
6. + channels and insulinotrophic action by the antiarrhythmic agent, cibenzoline
7. Inhibition of the ATP-sensitive potassium channel by class I antiarrhythmic agent, cibenzoline, in rat pancreatic beta-cells
8. Evidence for a direct stimulatory effect of cibenzoline on insulin secretion in rats
9. + channels and enhances insulin release
10. Comparative studies of ATP sensitive potassium channels in heart and pancreatic β cells using Vaughan-Williams class Ia antiarrhythmics
11. Effect of cibenzoline treatment on glucose metabolism in patients with tachyarrhythmia
12. Cibenzoline plasma concentration and antiarrhyhmic effect
13. Pharmacokinetics of oral cibenzoline in arrhythmia patients
14. Relationship between serum trough concentrations of cibenzoline and fasting blood glucose levels in inpatients received cibenzoline therapy
15. Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: A cost-effectiveness analysis
16. Impact of vancomycin therapeutic drug monitoring on patient care
17. Therapeutic drug monitoring reduces toxic drug reactions: A meta-analysis
18. Organization and efficacy of a therapeutic drug monitoring consultation service in a pediatric hospital